News

Find News

Filter articles

Applied Filters

Showing 791 to 800 of 910 results

Janssen and Grünenthal sue Watson over Nucynta generic

US24-07-2014Legal developments

Johnson & Johnson’s pharmaceutical subsidiary Janssen and Germany-based pharmaceutical company Grünenthal have sued Watson Laboratories for infringing patents related to painkiller Nucynta (tapentadol hydrochloride).

Mylan lands injunction against GSK’s Paroxetine

US22-07-2014Legal developments

The US District Court for the District of New Jersey has granted Mylan its motion for a permanent injunction against GlaxoSmithKline’s (GSK’s) Paroxetine CR.

MPP signs licences to increase access to HIV drugs

Switzerland18-07-2014

The Medicines Patent Pool (MPP) has announced seven new sub-licensing agreements to make generic HIV medicines atazanavir (ATV) and dolutegravir (DTG).

Alcon responds to Aurobindo’s proposed Vigamox generic

US17-07-2014Legal developments

Novartis’s eye care unit Alcon Pharmaceuticals has sued Hyderabad-based Aurobindo Pharma for infringing two patents covering its eye drop solution Vigamox (moxifloxacin hydrochloride) at the US District Court for the District of Delaware.

Acorda challenges Actavis’s Ampyra generic

US09-07-2014

US-based Acorda Therapeutics has sued Actavis for infringing four patents covering its multiple sclerosis (MS) drug Ampyra (dalfampridine).

Aurobindo sued by Pfizer over skin antibiotic

US04-07-2014

Pfizer has launched a lawsuit against Aurobindo Pharma accusing the Indian pharmaceutical company of infringing patents related to an antibiotic used to treat skin infections.

Forest sues to stop Aurobindo’s generic Namenda

US30-06-2014Legal developments

New York-headquartered Forest Laboratories has filed suit against Indian company Aurobindo Pharma to protect Namenda, a treatment for moderate to severe Alzheimer’s disease.

Indian Patent Office rejects anti-cancer drug patent

India24-06-2014

The Indian Patent Office has rejected a patent application for an anti-cancer drug for the second time, paving the way for generic versions to potentially enter the market.

Canada and Australia in new stem cell partnership

Australia, Canada16-06-2014

Stem cell research companies in Canada and Australia have teamed up to support increased research and development in both countries.

Actavis and Zydus settle Asacol patent dispute

Ireland, US10-06-2014

Irish-based drug manufacturer Actavis has settled its patent dispute with Zydus Pharmaceuticals.

Showing 791 to 800 of 910 results

LSIPR